Skip to main content

Table 1 Patient characteristics and potential risk factors for mortality associated with A. baumannii infections (N = 111)

From: Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon

Information

n (%)

Sex

Male

69 (62.2)

Female

42 (37.8)

Age (years)

 < 45

10 (9)

45–54

6 (5.4)

55–64

27 (24.3)

65–74

20 (18)

 ≥ 75

48 (43.2)

Mean ± standard deviation: 68 ± 16

 

Range: 23–97

 

Department of infection acquisition

Intensive care unit

85 (76.6)

Internal medicine

13 (11.7)

Cardiac care unit

9 (8.1)

Surgery

3 (2.7)

Oncology

1 (0.9)

Season of infection acquisition

Winter

49 (44.1)

Spring

18 (16.2)

Summer

31 (27.9)

Fall

13 (11.7)

Potential pre-admission risk factors

Underlying medical conditionsa

Hypertension

72 (64.9)

Diabetes mellitus type II

63 (56.8)

Chronic kidney disease

37 (33.3)

Coronary artery disease

37 (33.3)

Neutropenia

33 (29.7)

Thrombocytopenia

30 (27)

Solid neoplasia

26 (23.4)

Dyslipidemia

22 (19.8)

Blood transfusion

22 (19.8)

Chronic obstructive lung disease

13 (11.7)

Cerebrovascular disease

12 (10.8)

Dementia

12 (10.8)

Congestive heart failure

10 (9)

Peripheral vascular disease

7 (6.3)

Epilepsy

3 (2.7)

Lymphoma

3 (2.7)

Leukemia

3 (2.7)

Peptic ulcer

3 (2.7)

Polytrauma

2 (1.8)

Solid organ transplant

1 (0.9)

HIV/AIDS

1 (0.9)

Hospitalization within the last three months

12 (10.8)

Use of antibiotics within the last three months

14 (12.6)

Use of glucocorticoids within the last four weeksb

13 (11.7)

Use of chemotherapy within the last three months

10 (9.1%)

Potential post-admission risk factors

Length of hospital stay prior to infection acquisition (days)

Mean ± standard deviation: 12.23 ± 8.25

 

Invasive medical procedures within 30 days prior to infection acquisitiona

Mechanical ventilation

78 (70.3)

Indwelling urethral catheterization

73 (65.8)

Central venous line

58 (52.3)

Surgery

23 (20.7)

Prolonged total parenteral nutrition

23 (20.7)

Renal replacement therapy (dialysis)

20 (18)

  1. aAs multiple responses were recorded from certain patients, numbers do not add up to 111
  2. b≥ 10 mg of prednisolone daily for > 5 days within 4 weeks prior to the onset of infection (or an equivalent glucocorticoid and dosage)